How patients take malaria treatment: A systematic review of the literature on adherence to antimalarial drugs

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Bruxvoort, Katia ^a,b   Goodman, Catherine ^a   Patrick Kachur, S ^c   Schellenberg, David ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; DOXYCYCLINE; MEFLOQUINE; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; TETRACYCLINE; AMODIAQUINE PLUS ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE PLUS PRIMAQUINE; ARTEMISININ; ARTEMISININ DERIVATIVE;

CONSULTATION; DIAGNOSTIC TEST; HUMAN; INFORMED CONSENT; MALARIA; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PLASMODIUM VIVAX MALARIA; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF REPORT; SOCIAL INTERACTION; STUDY DESIGN; SYSTEMATIC REVIEW; TREATMENT DURATION; AWARENESS; HEALTH AUXILIARY; METHODOLOGY; STATISTICS AND NUMERICAL DATA;

ANTIMALARIALS; ARTEMISININS; HUMANS; MALARIA; PATIENT COMPLIANCE;

EID: 84901694335     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084555     Document Type: Review

References (78)

1. World Health Organization (2012) World Malaria Report.
2. World Health Organization (2010) Guidelines for the treatment of malaria. Geneva, Switzerland.
3. Bloland PB (2003) A contrarian view of malaria therapy policy in Africa. Am J Trop Med Hyg 68: 125-126.
4. Krause G, Sauerborn R (2000) Comprehensive community effectiveness of health care. A study of malaria treatment in children and adults in rural Burkina Faso. Ann Trop Paediatr 20: 273-282.
5. White NJ, Pongtavornpinyo W (2003) The de novo selection of drug-resistant malaria parasites. Proc Biol Sci 270: 545-554. (Pubitemid 36308233)
6. Keoluangkhot V, Green MD, Nyadong L, Fernandez FM, Mayxay M, et al. (2008) Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether. Am J Trop Med Hyg 78: 552-555. (Pubitemid 351845155)
7. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, et al. (2009) Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J 8: 253.
8. Yeung S, White NJ (2005) How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health 10: 121-138. (Pubitemid 40269162)
9. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356: 297-302. (Pubitemid 30459588)
10. Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, et al. (1997) Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 91: 574-577. (Pubitemid 27478651)
11. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, et al. (2000) Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. The Lancet 355: 352-357.
12. Dorsey G, Vlahos J, Kamya MR, Staedke SG, Rosenthal PJ (2003) Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. J Infect Dis 188: 1231-1238. (Pubitemid 37338988)
13. Rao VB, Schellenberg D, Ghani AC (2013) Overcoming health systems barriers to successful malaria treatment. Trends Parasitol 29: 164-180.
14. Beer N, Ali AS, Rotllant G, Abass AK, Omari RS, et al. (2009) Adherence to artesunate-amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania. Trop Med Int Health 14: 766-774.
15. Chinbuah AM, Gyapong JO, Pagnoni F, Wellington EK, Gyapong M (2006) Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Trop Med Int Health 11: 1003-1016. (Pubitemid 44015239)
16. Cohen JL, Yavuz E, Morris A, Arkedis J, Sabot O (2012) Do patients adhere to over-the-counter artemisinin combination therapy for malaria? Evidence from an intervention study in Uganda. Malar J 11: 83.
17. Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, et al. (2004) Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health 9: 62-67. (Pubitemid 38178013)
18. Depoortere E, Salvador ET, Stivanello E, Bisoffi Z, Guthmann JP (2004) Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan. Ann Trop Med Parasitol 98: 635-637. (Pubitemid 39215518)
19. Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, et al. (2004) Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg 71: 525-530. (Pubitemid 39601144)
20. Gerstl S, Dunkley S, Mukhtar A, Baker S, Maikere J (2010) Successful introduction of artesunate combination therapy is not enough to fight malaria: results from an adherence study in Sierra Leone. Trans R Soc Trop Med Hyg 104: 328-335.
21. Peeters Grietens K, Soto V, Erhart A, Ribera JM, Toomer E, et al. (2010) Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Am J Trop Med Hyg 82: 1017-1023.
22. Kabanywanyi AM, Lengeler C, Kasim P, King'eng'ena S, Schlienger R, et al. (2010) Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malar J 9: 48.
23. Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, et al. (2004) Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg 71: 715-722. (Pubitemid 40075619)
24. Kalyango JN, Rutebemberwa E, Karamagi C, Mworozi E, Ssali S, et al. (2013) High adherence to antimalarials and antibiotics under integrated community case management of illness in children less than five years in eastern Uganda. PLoS One 8: e60481.
25. Khantikul N, Butraporn P, Kim HS, Leemingsawat S, Tempongko MA, et al. (2009) Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand. J Health Popul Nutr 27: 4-13.
26. Kolaczinski JH, Ojok N, Opwonya J, Meek S, Collins A (2006) Adherence of community caretakers of children to pre-packaged antimalarial medicines (HOMAPAK) among internally displaced people in Gulu district, Uganda. Malar J 5: 40.
27. Lawford H, Zurovac D, O'Reilly L, Hoibak S, Cowley A, et al. (2011) Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya. Malar J 10: 281.
28. Lemma H, Lofgren C, San Sebastian M (2011) Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia. Malar J 10: 349.
29. Mace KE, Mwandama D, Jafali J, Luka M, Filler SJ, et al. (2011) Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural Malawi. Clin Infect Dis 53: 772-779.
30. Nshakira N, Kristensen M, Ssali F, Whyte SR (2002) Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda. Trop Med Int Health 7: 309-316. (Pubitemid 34595598)
31. Pereira EA, Ishikawa EA, Fontes CJ (2011) Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region. Malar J 10: 355.
32. Reilley B, Abeyasinghe R, Pakianathar MV (2002) Barriers to prompt and effective treatment of malaria in northern Sri Lanka. Trop Med Int Health 7: 744-749.
33. Simba DO, Kakoko D, Tomson G, Premji Z, Petzold M, et al. (2012) Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania. Trans R Soc Trop Med Hyg 106: 3-9.
34. Twagirumukiza M, Kayumba PC, Kips JG, Vrijens B, Stichele RV, et al. (2010) Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants. Malar J 9: 206.
35. Abuaku BK, Koram KA, Binka FN (2004) Antimalarial drug use among caregivers in Ghana. Afr Health Sci 4: 171-177.
36. Ajayi IO, Browne EN, Bateganya F, Yar D, Happi C, et al. (2008) Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J 7: 190.
37. Amin AA, Hughes DA, Marsh V, Abuya TO, Kokwaro GO, et al. (2004) The difference between effectiveness and efficacy of antimalarial drugs in Kenya. Trop Med Int Health 9: 967-974. (Pubitemid 39278997)
38. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, et al. (2005) Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2: e330.
39. Deming MS, Gayibor A, Murphy K, Jones TS, Karsa T (1989) Home treatment of febrile children with antimalarial drugs in Togo. Bull World Health Organ 67: 695-700. (Pubitemid 20090340)
40. Nsungwa-Sabiiti J, Tomson G, Pariyo G, Ogwal-Okeng J, Peterson S (2005) Community effectiveness of malaria treatment in Uganda-a long way to Abuja targets. Ann Trop Paediatr 25: 91-100. (Pubitemid 41131127)
41. Onyango EO, Ayodo G, Watsierah CA, Were T, Okumu W, et al. (2012) Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya. BMC Infect Dis 12: 143.
42. Thera MA, D'Alessandro U, Thiero M, Ouedraogo A, Packou J, et al. (2000) Child malaria treatment practices among mothers in the district of Yanfolila, Sikasso region, Mali. Trop Med Int Health 5: 876-881. (Pubitemid 32115926)
43. Agyepong IA, Ansah E, Gyapong M, Adjei S, Barnish G, et al. (2002) Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana. Soc Sci Med 55: 2215-2226. (Pubitemid 36158955)
44. Ansah EK, Gyapong JO, Agyepong IA, Evans DB (2001) Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health 6: 496-504. (Pubitemid 32664630)
45. Denis MB (1998) Improving compliance with quinine + tetracycline for treatment of malaria: evaluation of health education interventions in Cambodian villages. Bull World Health Organ 76 Suppl 1: 43-49.
46. Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, et al. (2011) The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial. PLoS Med 8: e1000437.
47. Lauwo JA, Hombhanje FW, Tulo SP, Maibani G, Bjorge S (2006) Impact of pre-packaging antimalarial drugs and counselling on compliance with malaria treatment at Port Moresby General Hospital Adult Outpatient Department. P N G Med J 49: 14-21.
48. Marsh VM, Mutemi WM, Muturi J, Haaland A, Watkins WM, et al. (1999) Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Trop Med Int Health 4: 383-389. (Pubitemid 29283083)
49. Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, et al. (2004) Improving malaria home treatment by training drug retailers in rural Kenya. Trop Med Int Health 9: 451-460. (Pubitemid 38582228)
50. Okonkwo PO, Akpala CO, Okafor HU, Mbah AU, Nwaiwu O (2001) Compliance to correct dose of chloroquine in uncomplicated malaria correlates with improvement in the condition of rural Nigerian children. Trans R Soc Trop Med Hyg 95: 320-324. (Pubitemid 33713087)
51. Qingjun L, Jihui D, Laiyi T, Xiangjun Z, Jun L, et al. (1998) The effect of drug packaging on patients' compliance with treatment for Plasmodium vivax malaria in China. Bull World Health Organ 76 Suppl 1: 21-27. (Pubitemid 128685310)
52. Shwe T, Lwin M, Aung S (1998) Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community-based treatment of non-severe falciparum malaria in Myanmar. Bull World Health Organ 76 Suppl 1: 35-41. (Pubitemid 128685312)
53. Sirima SB, Konate A, Tiono AB, Convelbo N, Cousens S, et al. (2003) Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health 8: 133-139. (Pubitemid 36269364)
54. Winch PJ, Bagayoko A, Diawara A, Kane M, Thiero F, et al. (2003) Increases in correct administration of chloroquine in the home and referral of sick children to health facilities through a community-based intervention in Bougouni District, Mali. Trans R Soc Trop Med Hyg 97: 481-490. (Pubitemid 40590075)
55. Yeboah-Antwi K, Gyapong JO, Asare IK, Barnish G, Evans DB, et al. (2001) Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ 79: 394-399. (Pubitemid 32488014)
56. Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, et al. (2009) Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ 339: b2763.
57. Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, et al. (2009) Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J 8: 204.
58. Dunyo S, Sirugo G, Sesay S, Bisseye C, Njie F, et al. (2011) Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. PLoS One 6: e17371.
59. Fungladda W, Honrado ER, Thimasarn K, Kitayaporn D, Karbwang J, et al. (1998) Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand. Bull World Health Organ 76 Suppl 1: 59-66. (Pubitemid 128685315)
60. Faucher JF, Aubouy A, Adeothy A, Cottrell G, Doritchamou J, et al. (2009) Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. J Infect Dis 200: 57-65.
61. Rahman MM, Dondorp AM, Day NP, Lindegardh N, Imwong M, et al. (2008) Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Trans R Soc Trop Med Hyg 102: 861-867.
62. Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, et al. (2010) Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J 9: 308.
63. Congpuong K, Bualombai P, Banmairuroi V, Na-Bangchang K (2010) Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria. Malar J 9: 43.
64. Na-Bangchang K, Congpuong K, Sirichaisinthop J, Suprakorb K, Karbwang J (1997) Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria. Br J Clin Pharmacol 43: 639-642. (Pubitemid 27283574)
65. Souares A, Lalou R, Sene I, Sow D, Le Hesran JY (2008) Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal. Trans R Soc Trop Med Hyg 102: 751-758. (Pubitemid 351907775)
66. Yepez MC, Zambrano D, Carrasco F, Yepez RF (2000) [The factors associated with noncompliance with antimalarial treatment in Ecuadorian patients]. Rev Cubana Med Trop 52: 81-89.
67. Duarte EC, Gyorkos TW (2003) Self-reported compliance with last malaria treatment and occurrence of malaria during follow-up in a Brazilian Amazon population. Trop Med Int Health 8: 518-524. (Pubitemid 36724016)
68. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, et al. (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376: 1647-1657.
69. Hodel EM, Genton B, Zanolari B, Mercier T, Duong S, et al. (2010) Residual antimalarial concentrations before treatment in patients with malaria from Cambodia: indication of drug pressure. J Infect Dis 202: 1088-1094.
70. Hodel EM, Kabanywanyi AM, Malila A, Zanolari B, Mercier T, et al. (2009) Residual antimalarials in malaria patients from Tanzania-implications on drug efficacy assessment and spread of parasite resistance. PLoS One 4: e8184.
71. Blomstedt Y, Souares A, Niamba L, Sie A, Weinehall L, et al. (2012) Measuring self-reported health in low-income countries: piloting three instruments in semi-rural Burkina Faso. Glob Health Action 5.
72. Das J, Hammer J, Sanchez-Paramo C (2011) The impact of recall periods on reported morbidity and health-seeking behavior. World Bank.
73. Souares A, Moulin P, Sarrassat S, Carlotti MP, Lalou R, et al. (2009) Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal. Malar J 8: 257.
74. Wiesner L, Barnes K (2011) Personal communication.
75. Clark S, Lal S, Mbonye A (2011) Study protocol: Introducing rapid diagnostic tests (RDTs) into the private health sector in Uganda- a randomised trial among registered drug shops to evaluate impact on antimalarial drug use.
76. Cohen JL (2011) Study protocol: Determining the impact of packaging and rapid diagnostic tests on adherence rates to artemether lumefantrine. Clinton Health Access Initiative.
77. Fink G, Goldberg J (2011) Preserving ACTs: PACT Pilot Report Cape Coast, Ghana.
78. Bruxvoort K, Festo C, Kalolella A, Cairns M, Kachur P, et al. (2012) Study protocol: Cluster-randomized trial of text message reminders to retail staff of appropriate practices for dispensing artemether-lumefantrine in drug shops in Tanzania: effect on dispenser knowledge and patient adherence.